18E7HLAIITCR

Jianting Long1, Xihe Chen2, Mian He3

  • 1Department of Oncology, Cancer Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China.

Nature communications
|March 14, 2024
PubMed
概括

研究人员发现了一种新的T细胞受体 (TCR),向宫癌中的HPV18. 这种TCR在临床前模型中显示出强大的抗瘤活性,目前正在HPV18阳性癌症的I期临床试验中.